PCDH20 and malignant colon neoplasm: Furthermore, we found beneficial-cluster of specific methylation markers (PCDH20, APCDD1, COCH) that could be used in conjunction with microsatellite status to expand the pool of colon cancer patients eligible for immunotherapy.